Cytomegalovirus (CMV) infection causes significant morbidity and mortality among
transplant recipients. Although it is still not clear if a preemptive strategy is superior to a …

Despite preexisting cytomegalovirus (CMV) immunity, CMV‐seropositive liver
transplantation (LT) patients remain at risk of CMV infection. We hypothesized that the pre …

Purpose To evaluate epidemiology, risk‐factors, and outcomes of high‐level (HL)
cytomegalovirus (CMV) viremia in liver transplant recipients. Methods Adult patients …

Background Recent studies have demonstrated that cytomegalovirus (CMV) infection and
disease are associated with increased risk of graft loss and death in high‐risk (donor CMV …

A vast majority of the transplant recipients are cytomegalovirus (CMV)‐seropositive (R+). We
sought to assess variables predictive of CMV infection, specifically in R+ liver transplant …

Background Cytomegalovirus (CMV) is one of the most common post‐transplant viral
infections causing significant morbidity and occasional mortality. Limited literature on the …

BACKGROUND: Cytomegalovirus (CMV) infections are among the most common infections
following liver transplantation. The main preventive methods for CMV infections are …

In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been
inconsistently associated with increased mortality in liver transplant (LT) recipients. A …

Cytomegalovirus (CMV) is a major cause of morbidity and mortality following solid organ
transplantation (SOT). Two strategies, prophylactic, and preemptive have emerged for the …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …